^
    1m
    Illumina to Offer More Pillar Cancer Panels as Part of Expanded Partnership (Genomeweb)
    "Pillar Biosciences said Wednesday that more of its OncoReveal next-generation sequencing panels will be offered by Illumina in an expansion of the companies’ existing partnership...The deal includes the OncoReveal Essential MPN, Myeloid, Multi-Cancer with CNV and Fusion panel, and BRCA1 and BRCA2 plus CNV panel, which will be available as part of validated workflows on the MiSeq i100 sequencer launched last week."
    Licensing / partnership
    |
    OncoReveal™ BRCA1 & BRCA2 plus CNV Panel • OncoReveal™ Myeloid Panel • oncoReveal™ Core LBx • oncoReveal™ Fusion LBx Panel • oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel • oncoReveal™ Solid Tumor v2 Panel
    1year
    Beckman Coulter Life Sciences and Pillar Biosciences announce NGS application development pipeline for the Biomek NGeniuS System (Pillar Biosciences Press Release)
    "Beckman Coulter Life Sciences...announces a collaboration agreement with Pillar Biosciences, which develops and distributes IVD & RUO NGS testing solutions based on their proprietary SLIMamp® technology to help localize patient testing and optimize the selection of precision therapies for cancer patients...The application development partnership is initially focused on five commercially-available, solid tumor liquid biopsy and hematology panels from Pillar Biosciences..."
    Licensing / partnership
    |
    OncoReveal™ Solid Tumor Panel • oncoReveal™ Core LBx • oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel • oncoReveal™ Solid Tumor v2 Panel